Royce & Associates’s Dillards DDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Buy
24,120
+4,123
+21% +$2.38M 0.1% 325
2026
Q1
$11.4M Sell
19,997
-570
-3% -$356K 0.11% 289
2025
Q4
$12.5M Sell
20,567
-2,780
-12% -$1.75M 0.13% 242
2025
Q3
$14.3M Sell
23,347
-2,531
-10% -$1.31M 0.14% 217
2025
Q2
$10.8M Buy
25,878
+5,640
+28% +$2.1M 0.11% 270
2025
Q1
$7.25M Sell
20,238
-5,760
-22% -$2.48M 0.08% 372
2024
Q4
$11.2M Sell
25,998
-5,510
-17% -$2.26M 0.1% 284
2024
Q3
$12.1M Sell
31,508
-710
-2% -$271K 0.11% 266
2024
Q2
$14.2M Sell
32,218
-1,010
-3% -$437K 0.13% 220
2024
Q1
$15.7M Sell
33,228
-1,210
-4% -$496K 0.14% 203
2023
Q4
$13.9M Sell
34,438
-2,600
-7% -$882K 0.13% 215
2023
Q3
$12.3M Sell
37,038
-1,335
-3% -$441K 0.12% 221
2023
Q2
$12.5M Buy
38,373
+1,500
+4% +$459K 0.12% 233
2023
Q1
$11.3M Sell
36,873
-3,400
-8% -$1.21M 0.11% 263
2022
Q4
$13M Sell
40,273
-1,301
-3% -$423K 0.14% 222
2022
Q3
$11.3M Buy
41,574
+1,500
+4% +$397K 0.13% 241
2022
Q2
$8.84M Buy
40,074
+5,000
+14% +$1.44M 0.09% 317
2022
Q1
$9.41M Buy
35,074
+9,301
+36% +$2.4M 0.08% 381
2021
Q4
$6.32M Sell
25,773
-27,647
-52% -$7.27M 0.05% 508
2021
Q3
$9.22M Sell
53,420
-20,080
-27% -$3.82M 0.07% 441
2021
Q2
$13.3M Buy
+73,500
New +$9.48M 0.09% 374
2020
Q2
Sell
-1,319
Closed -$49K 1178
2020
Q1
$49K Buy
1,319
+1,305
+9,321% +$76.3K ﹤0.01% 1009
2019
Q4
$1K Hold
14
﹤0.01% 1124
2019
Q3
$1K Sell
14
-13,591
-100% -$869K ﹤0.01% 1137
2019
Q2
$847K Sell
13,605
-10,554
-44% -$679K 0.01% 851
2019
Q1
$1.74M Sell
24,159
-7,888
-25% -$542K 0.01% 774
2018
Q4
$1.93M Sell
32,047
-3,066
-9% -$211K 0.02% 740
2018
Q3
$2.68M Hold
35,113
0.02% 760
2018
Q2
$3.32M Hold
35,113
0.02% 708
2018
Q1
$2.82M Hold
35,113
0.02% 762
2017
Q4
$2.11M Sell
35,113
-88,069
-71% -$4.88M 0.01% 835
2017
Q3
$6.91M Sell
123,182
-16,299
-12% -$1M 0.05% 479
2017
Q2
$8.05M Buy
139,481
+41,098
+42% +$2.17M 0.05% 450
2017
Q1
$5.14M Sell
98,383
-461,105
-82% -$25.2M 0.03% 570
2016
Q4
$35.1M Buy
559,488
+286,908
+105% +$18.8M 0.23% 131
2016
Q3
$17.2M Sell
272,580
-586,357
-68% -$36.7M 0.11% 253
2016
Q2
$52.1M Buy
858,937
+245,015
+40% +$16M 0.34% 68
2016
Q1
$52.1M Sell
613,922
-45,800
-7% -$3.43M 0.33% 73
2015
Q4
$43.4M Buy
659,722
+34,367
+5% +$2.77M 0.26% 101
2015
Q3
$54.6M Buy
+625,355
New +$60.5M 0.29% 93
2014
Q4
Sell
-18,286
Closed -$1.99M 1328
2014
Q3
$1.99M Sell
18,286
-46,100
-72% -$5.36M 0.01% 1008
2014
Q2
$7.51M Sell
64,386
-51,400
-44% -$5.37M 0.02% 763
2014
Q1
$10.7M Buy
115,786
+13,000
+13% +$1.18M 0.03% 648
2013
Q4
$9.99M Buy
102,786
+43,400
+73% +$3.76M 0.03% 673
2013
Q3
$4.65M Buy
59,386
+14,000
+31% +$1.13M 0.01% 865
2013
Q2
$3.72M Buy
+45,386
New +$3.84M 0.01% 923

Other funds holding DDS

Royce & Associates's DDS Position: Q2 2026 in Review

Royce & Associates increased its Dillards (DDS) stake by 21% in Q2 2026, buying an estimated $2.38M and bringing the position to 24,120 shares worth $12.7M. The position accounts for 0.1% of the portfolio, ranked #325.

Royce & Associates first reported a position in DDS in Q2 2013 and has held it in 46 quarters since. The position peaked at $54.6M in Q3 2015. 311 funds tracked by Wall St. Rank hold DDS as of Q2 2026.

  • Royce & Associates held 24,120 shares of Dillards worth $12.7M as of Q2 2026.
  • Royce & Associates bought 4,123 Dillards shares in Q2 2026, an estimated $2.38M.
  • Dillards made up 0.1% of Royce & Associates's portfolio in Q2 2026, its #325 holding.
  • Royce & Associates first reported a position in Dillards in Q2 2013 and has held it in 46 quarters since.
  • Royce & Associates's Dillards position peaked at $54.6M in Q3 2015.
  • 311 funds tracked by Wall St. Rank held Dillards as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.